|
| 华康医疗(301235)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-07-28 | 5464.80 | 51.75% | 10560.00 | 0.00 | 5095.20 | 48.25% | 追加承诺限售股份上市流通 | | 2024-02-08 | 105.60 | 1.00% | 5095.20 | 5464.80 | 4989.60 | 47.25% | 首发战略配售股份 | | 2023-07-28 | 2.85 | 0.03% | 4993.82 | 5566.18 | 4990.97 | 47.26% | 追加承诺限售股份上市流通 | | 2023-01-30 | 2531.23 | 23.97% | 5014.34 | 5545.66 | 5014.34 | 47.48% | 首发原股东限售股份,首发战略配售股份 | | 2022-07-28 | 129.34 | 1.22% | 2496.70 | 8063.30 | 2496.70 | 23.64% | 首发机构配售股份 | | 2022-01-28 | 2326.18 | 22.03% | 2326.18 | 8233.82 | 2326.18 | 22.03% | 首发一般股份 |
|